|Bid||483.25 x 0|
|Ask||485.00 x 0|
|Day's range||480.20 - 480.20|
|52-week range||301.30 - 486.25|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Anthem (ELV) delivered earnings and revenue surprises of 4.15% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.